PT90066A - Processo para a preparacao de compostos que inibem a biosintese de metabolitos do acido araquidonico derivados de lipoxigenase - Google Patents

Processo para a preparacao de compostos que inibem a biosintese de metabolitos do acido araquidonico derivados de lipoxigenase

Info

Publication number
PT90066A
PT90066A PT90066A PT9006689A PT90066A PT 90066 A PT90066 A PT 90066A PT 90066 A PT90066 A PT 90066A PT 9006689 A PT9006689 A PT 9006689A PT 90066 A PT90066 A PT 90066A
Authority
PT
Portugal
Prior art keywords
biasintese
lipoxigenase
metabolites
inhibit
compounds
Prior art date
Application number
PT90066A
Other languages
English (en)
Other versions
PT90066B (pt
Inventor
Edward S Lazer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT90066A publication Critical patent/PT90066A/pt
Publication of PT90066B publication Critical patent/PT90066B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/373Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
PT90066A 1988-03-21 1989-03-21 Processo para a preparacao de compostos que inibem a biosintese de metabolitos do acido araquidonico derivados de lipoxigenase PT90066B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17051288A 1988-03-21 1988-03-21

Publications (2)

Publication Number Publication Date
PT90066A true PT90066A (pt) 1989-11-10
PT90066B PT90066B (pt) 1994-05-31

Family

ID=22620151

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90066A PT90066B (pt) 1988-03-21 1989-03-21 Processo para a preparacao de compostos que inibem a biosintese de metabolitos do acido araquidonico derivados de lipoxigenase

Country Status (16)

Country Link
EP (1) EP0334119B1 (pt)
JP (1) JPH024729A (pt)
KR (1) KR890014514A (pt)
AU (1) AU628324B2 (pt)
DD (1) DD283602A5 (pt)
DE (1) DE68907095T2 (pt)
DK (1) DK134489A (pt)
ES (1) ES2056983T3 (pt)
FI (1) FI891295A (pt)
HU (2) HU9201174D0 (pt)
IL (1) IL89666A0 (pt)
NO (1) NO169648C (pt)
NZ (1) NZ228410A (pt)
PH (1) PH26928A (pt)
PT (1) PT90066B (pt)
ZA (1) ZA892086B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626955A1 (en) * 1992-02-11 1994-12-07 Allergan, Inc. Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
ES2089736T3 (es) * 1992-10-28 1996-10-01 Shionogi & Co Derivados de bencilideno.
ES2087019B1 (es) * 1994-02-08 1997-03-16 Bobel246 S L Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6376524B1 (en) * 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
ES2401077T3 (es) 2001-01-18 2013-04-16 Glaxo Group Limited Nuevos derivados 1,2-difenileteno para el tratamiento de enfermedades inmunológicas
MXPA04000695A (es) 2001-07-23 2005-08-26 Galileo Pharmaceuticals Inc Compuestos citoprotectores, formulaciones farmaceuticas y cosmeticas y metodos.
US20070185217A1 (en) 2003-12-23 2007-08-09 Abraxis Bioscience, Inc. Propofol analogs, process for their preparation, and methods of use
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
EP3706725A4 (en) 2017-11-10 2021-08-25 Dermavant Sciences GmbH PROCESS FOR THE PREPARATION OF TAPINAROF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3188315A (en) * 1960-05-18 1965-06-08 Schering Corp Novel compounds for lowering blood cholesterol levels
FR1390978A (fr) * 1963-11-20 1965-03-05 Ind Chimique Sa Procédé de préparation de l'alpha-(thiényl-2) 4-hydroxystilbène et de quelques dérivés et produits obtenus
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1338645C (en) * 1987-01-06 1996-10-15 George R. Pettit Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"

Also Published As

Publication number Publication date
PT90066B (pt) 1994-05-31
KR890014514A (ko) 1989-10-24
HU9201174D0 (en) 1992-07-28
ES2056983T3 (es) 1994-10-16
FI891295A0 (fi) 1989-03-20
DE68907095D1 (de) 1993-07-22
ZA892086B (en) 1990-11-28
IL89666A0 (en) 1989-09-28
FI891295A (fi) 1989-09-22
DK134489D0 (da) 1989-03-20
EP0334119A1 (en) 1989-09-27
AU3151489A (en) 1989-09-21
HUT50093A (en) 1989-12-28
EP0334119B1 (en) 1993-06-16
DK134489A (da) 1989-09-22
DE68907095T2 (de) 1994-01-05
PH26928A (en) 1992-12-03
JPH024729A (ja) 1990-01-09
AU628324B2 (en) 1992-09-17
DD283602A5 (de) 1990-10-17
NZ228410A (en) 1993-08-26
NO891114L (no) 1989-09-22
NO891114D0 (no) 1989-03-15
NO169648C (no) 1992-07-22
HU207858B (en) 1993-06-28
NO169648B (no) 1992-04-13

Similar Documents

Publication Publication Date Title
BR8801098A (pt) Processo para a preparacao de um composto de imidazola
BR8500141A (pt) Processo para a preparacao de compostos cotelomeros
BR8501583A (pt) Processo para a preparacao de compostos
PT89264A (pt) Processo para a preparacao de compostos azabiciclicos
PT83152B (pt) Processo para a preparacao de compostos di-t-butilfenoicos
PT91068A (pt) Processo para a preparacao de compostos biarilo
BR9105080A (pt) Processo para a preparacao de um acido alcoxialcanoico
PT82062B (pt) Processo para a preparacao de compostos piridinilimidazolidinona
BR8801269A (pt) Processo para a preparacao de um composto de ciano-imidazol
BR8601962A (pt) Processo para a preparacao de compostos
PT91872A (pt) Processo para a preparacao de compostos azabiciclicos
BR8900541A (pt) Processo para a preparacao de um composto quimico
BR8900137A (pt) Processo para a fabricacao de um eixo composto
PT84778B (pt) Processo para a preparacao de compostos derivados de tiazolotriazol
PT82678B (pt) Processo para a preparacao de compostos de cinolina
BR8806354A (pt) Processo para a metilacao de um composto
PT90066A (pt) Processo para a preparacao de compostos que inibem a biosintese de metabolitos do acido araquidonico derivados de lipoxigenase
BR8903268A (pt) Processo para a preparacao de um derivado de acido pirazol carboxilico
PT80988B (pt) Processo para a preparacao de derivados de acido quinolocarboxilico
BR8804071A (pt) Processo para a preparacao de compostos de oxo-acil-hidrazida antioxidantes
PT89237A (pt) Processo para a preparacao de compostos beta-lactamicos
PT90267A (pt) Processo para a preparacao de compostos azabiciclicos
BR8800989A (pt) Processo para a preparacao de um composto
BR8706014A (pt) Processo para a preparacao de compostos
BR8602778A (pt) Processo para a preparacao de um composto

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931110

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950531